Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01901614 · ClinicalTrials.gov registry record · NA

OCT-guided LALAK for KCN

A NA study, sponsored by Oregon Health and Science University.

Terminated
Registry status
NA
Development phase
5
Enrollment target

NCT01901614 is a NA study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 5 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01901614, a NA study, was terminated before completion, sponsored by Oregon Health and Science University.

TERMINATED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

The purpose of this study is to determine if a new procedure, called laser-assisted lamellar anterior keratoplasty (LALAK), can achieve the same level of vision with a lower risk of potential complications after surgery compared to another corneal transplant procedure. The current procedure is called Intralase-enabled keratoplasty (IEK) and replaces the entire cornea. The LALAK procedure involves transplanting only the top layers of the cornea instead of the entire cornea. Only one eye will have this experimental procedure performed. If both eyes need to have surgery your doctor will help you decide on the best non-study option for your other eye.

Interventions

  • PROCEDURE LALAK
  • PROCEDURE IEK
  • DRUG Retrobulbar Block or General Anesthesia
  • DEVICE optical coherence tomography (OCT)
  • DRUG Topical Anesthesia

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2013-08
Est. Completion 2017-08-31
Phase NA

What the Registry Record Tells You About NCT01901614

The ClinicalTrials.gov registry entry for NCT01901614 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which LALAK is the first listed.

NCT01901614 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01901614 about?

NCT01901614 is a clinical study titled "OCT-guided LALAK for KCN". The purpose of this study is to determine if a new procedure, called laser-assisted lamellar anterior keratoplasty (LALAK), can achieve the same level of vision with a lower risk of potential complications after surgery compared to another corneal transplant procedure. The current procedure is calle...

What is the current status of trial NCT01901614?

This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2013-08. Estimated completion is 2017-08-31.

What interventions are being tested in trial NCT01901614?

The interventions under investigation include: LALAK (PROCEDURE), IEK (PROCEDURE), Retrobulbar Block or General Anesthesia (DRUG), optical coherence tomography (OCT) (DEVICE), Topical Anesthesia (DRUG).

Who is sponsoring clinical trial NCT01901614?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.